U.S. markets close in 34 minutes
  • S&P 500

    3,848.90
    -4.17 (-0.11%)
     
  • Dow 30

    31,064.88
    -111.13 (-0.36%)
     
  • Nasdaq

    13,550.88
    +19.97 (+0.15%)
     
  • Russell 2000

    2,153.96
    +12.54 (+0.59%)
     
  • Crude Oil

    52.21
    -0.92 (-1.73%)
     
  • Gold

    1,854.90
    -11.00 (-0.59%)
     
  • Silver

    25.53
    -0.32 (-1.25%)
     
  • EUR/USD

    1.2176
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • GBP/USD

    1.3679
    -0.0051 (-0.37%)
     
  • USD/JPY

    103.8200
    +0.3150 (+0.30%)
     
  • BTC-USD

    33,666.41
    +3,182.67 (+10.44%)
     
  • CMC Crypto 200

    666.05
    +56.06 (+9.19%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,631.45
    -125.41 (-0.44%)
     

CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference

CareDx, Inc.
·1 min read

SOUTH SAN FRANCISCO, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announces today it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11-13, 2020. CareDx’s management is scheduled to present on Wednesday, August 12, 2020, at 1:00 p.m. EDT. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at investors.caredxinc.com.

About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:

CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com

Investor Relations
Greg Chodaczek
646-924-1769
investor@caredx.com